2. UroToday Home
  3. Video Lectures

APCCC 2024 Videos

Comparing PSMA Ligands for Prostate Cancer Imaging - Michael Hofman
May 31, 2024
Details
Hypofractionation in Prostate Cancer Radiotherapy: Balancing Efficacy and Safety - Neha Vapiwala
May 28, 2024
Details
Escalation Strategies for Suboptimal PSA Decline in mHSPC - Mary-Ellen Taplin
May 28, 2024
Details
Testosterone Recovery After ADT: Timing, Predictive Factors, and Clinical Implications - Pierre Blanchard
May 28, 2024
Details
Radiating the Primary Tumor in Metastatic Hormone-Sensitive Prostate Cancer - Sandy Srinivas
May 28, 2024
Details
EMBARK Trial: Enzalutamide Monotherapy and Combination Therapy for High-Risk Biochemical Recurrence - Neal Shore
May 28, 2024
Details
Personalizing Salvage Radiation and Hormone Therapy for Biochemical Recurrence - Daniel Spratt
May 28, 2024
Details
Prognostic and Predictive Factors in Metastatic Hormone-Sensitive Prostate Cancer - Matthew Smith
May 24, 2024
Details
Optimizing Lutetium-PSMA Dosing in High-Volume Disease and Special Situations - Louise Emmett
May 24, 2024
Details
Sequencing Therapies in mCRPC After Progression on Combination Treatment - Ian Davis
May 24, 2024
Details
Managing Frail Patients with Metastatic Hormone-Sensitive Prostate Cancer - Maria De Santis
May 23, 2024
Details
Redefining Low-Volume Metastatic Prostate Cancer in the Era of PSMA PET Imaging - Oliver Sartor
May 23, 2024
Details
Optimal Imaging Standards for Metastatic Castration-Sensitive Prostate Cancer - Michael Morris
May 23, 2024
Details
The Use of PARP Inhibitors in mCRPC with BRCA1/2 Alterations - Joaquin Mateo
May 22, 2024
Details
Bone Health in Advanced Prostate Cancer: Findings from the STAMPEDE Trial and Hospital Episode Statistics - Noel Clarke
May 14, 2024
Details
APCCC 2024: Bridging Clinical Gaps in Prostate Cancer Care - Silke Gillessen
February 21, 2024
Details
Highlighting APCCC 2024: An International Prostate Cancer Meeting - Silke Gillessen & Aurelius Omlin
January 31, 2024
Details